Evgen Pharma financials at a glance

+ Portfolio

The revenue of Evgen Pharma is reported as 0.00055 billion Pounds in the fiscal year 2024. The earnings were -0.02 Pounds per share in 2024, which was 100 lower than 2022. And about -0.00489 billion Pounds are reported as free cash flow in the financials of Evgen Pharma 2024. No dividends were paid to the shareholders of the Evgen Pharma stock AIM:EVG in the financial year 2024.

£0.55M

Revenue

£-0.02

Earnings Per Share

0.00%

Gross Margin %

£-4.40M

Free Cash Flow

Revenue

0.55

Earnings Per Share

-0.02

Gross Margin %

0.00

Free Cash Flow

-4.40

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016
Rev.	Revenue	N/A	£0.55M	£0.00M	£0.27M	£0.00M	£0.00M	£0.00M	£0.00M	£0.00M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	£-0.01	£-0.02	£-0.01	£-0.03	£-0.03	£-0.03	£-0.04	£-0.05	£-0.07
Div.	Dividends	N/A	£0.00	£0.00	£0.00	£0.00	£0.00	£0.00	£0.00	£0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	274.89M	274.89M	274.89M	132.65M	98.99M	93.28M	73.27M	73.14M
OCF	Operating Cash Flow	N/A	£-4.89M	£-3.91M	£-4.79M	£-3.23M	£-3.47M	£-3.13M	£-4.06M	£0.00M
FCF	Free Cash Flow	N/A	£-4.40M	£-3.91M	£-4.12M	£-3.86M	£-3.47M	£-3.14M	£-4.07M	£0.00M
FCFS	Free Cash Flow Per Share	£-0.01	£-0.02	£-0.01	£-0.02	£-0.02	£-0.02	£-0.03	£-0.04	£-0.03

Evgen Pharma financials at a glance

Financials

Discover